Toxicology Positions

Our client is a small pharmaceutical company, which is very closely tied to a life sciences venture capital firm. In the last few years, this company has launched five spinoffs which have drug candidates in clinical phase development.

The company is evolving from the use of toxicology consultants; and has entrusted us to identify their first Toxicology Leader (AD, Director or Senior Director level). Qualified candidates will have an advanced degree, five or more years of experience and deep knowledge of large molecule safety assessment. The company primarily develops therapeutics for immunology and inflammation targets.

The person hired for this role will need to be willing to perform all the common tasks of a pharmaceutical toxicologist (project team participation, CRO selection and study design/management and interactions with the FDA and peer regulatory agencies), with no initial supervision. The role is US remote embraced and reports to the company’s VP Translational Research/Preclinical Sciences.

Our client company is a California based pharmaceutical company which is a recognized leader in novel therapeutic (RNA biology) development. They have engaged our services to identify and experienced toxicologic pathologist.

Baseline experience and credentials include ACVP Board certification and DVM and PhD degrees. The ideal candidate will have five or more years of toxicologic pathology experience, ideally in a drug development setting. Experience in digital pathology tools is desired.

The person hired for this role will act as an Anatomic Pathologist, supporting IND enabling toxicology studies across multiple species. He/She will, more broadly, contribute to preclinical strategy toward advancement of the company’s drug portfolio. The position will be onsite in the greater San Diego area and reports to a Senior Director of Pathology.

The Leyden Group associates have been asked by a Belgium based pharmaceutical company to hire an experienced toxicologist for an onsite role (ex-pat or permanent). The person they seek will have a doctoral degree and several years in preclinical safety assessment of large molecules (ideally immunologic agents). Those with only small molecule experience, and lacking some work with NHP species interpretations will not be considered for the role.

This person will independently act as a senior Project Toxicologist in providing portfolio strategy while being significantly engaged with their CRO and consulting partners. A person who also possesses the skills to mentor a small group of toxicologists would also be attractive.

The title and amount of experience required is flexible and may include a Director level person who could qualify as a successor for the present supervisor (Executive Director, Pharmacology/Toxicology). The company’s existing products and development pipeline is strong, with a high growth ceiling.